Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: John Bloxom who wrote (310)	12/3/1997 10:43:00 PM
From: chirodoc	Respond to of 887

<<<<<Intending no offense, this statement, as to the work of Judah Folkman, ......i understand that he is a great man. and i have read about his work. i do believe that anitangiogenesis has tremendous potential to save lives. .......i just have no proof that the COMPANY will make anyone any money in the next year--that is the wing and a prayer. ........there are so many biotechs that i am in love with due to their sophisiticated technology and their potential to help humanity. but i also want to make money on these babies and feel that without getting closer to pII/III trials it is hard to know what the chemicals will do. ......as an example look at rezulin--great chemical, great diabetic effects and it causes liver damage--who could have known? ......are you certain that these anti-angiogenesis treatments will in fact be profitable and save lives? if so do you buy entremed? sugen? or how about anit-sense? great idea! will it make money? who the hell knows right now--that is a wing and a prayer. .....sorry if i offended you--i have utmost respect for entremed.